COMMUNIQUÉS West-GlobeNewswire

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
05/11/2025
NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on November 1, 2025, the [...]
Praxis Precision Medicines to Participate in Upcoming Investor Conferences
05/11/2025
BOSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous [...]
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results
05/11/2025
Claseprubart achieved statistically significant and clinically meaningful improvements in Myasthenia Gravis Activities of Daily Living (MG-ADL), Quantitative Myasthenia Gravis (QMG), and other efficacy measures at Week [...]
LifeMD Reschedules Third Quarter 2025 Earnings Release and Conference Call to November 17
05/11/2025
NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual healthcare services and pharmacy, today announced that the Company has rescheduled its third quarter 2025 earnings [...]
Tarsus to Participate in Upcoming Investor Conference
05/11/2025
IRVINE, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to participate in a fireside chat at the Guggenheim 2 nd Annual Healthcare Innovation [...]
Benitec Biopharma Inc. Announces Proposed Public Offering
05/11/2025
HAYWARD, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines [...]
Novo Nordisk Wegovy® users achieved waist and BMI targets linked to improved health and low risk of obesity-related complications
05/11/2025
Unlike many other diseases, there are no set guidelines on treatment targets for obesity, and outcomes often rely on percentage weight loss only Body mass index (BMI) and waist-to-height ratio (a measurement of [...]
STERIS Announces Financial Results for Fiscal 2026 Second Quarter
05/11/2025
Total revenue from continuing operations increased 10%; constant currency organic revenue grew 9% As reported EPS from continuing operations increased to $1.94; adjusted EPS increased to $2.47 Fiscal 2026 constant [...]
BioRestorative Therapies to Report Third Quarter 2025 Financial Results and Host Conference Call on November 12, 2025
05/11/2025
MELVILLE, N.Y., Nov. 05, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc . (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX ) , a regenerative medicine innovator focused on stem cell-based therapies and [...]
PharmaCorp Announces C$15 Million Bought Deal Public Offering
05/11/2025
The Base Shelf Prospectus is accessible, and the Prospectus Supplement will be accessible within two business days, through SEDAR+ NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE [...]
SCYNEXIS Reports Third Quarter 2025 Financial Results and Provides Corporate Update
05/11/2025
SCYNEXIS to receive one-time payments totalling $24.8 million from GSK as part of the resolution of the disagreement related to the restart of the Phase 3 MARIO study in invasive candidiasis. Scynexis agreed to GSK’s [...]
FDA Warns Companies Over Illegal Marketing of Botox and Related Products
05/11/2025
Silver Spring, Md., Nov. 05, 2025 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration issued 18 warning letters to owners of websites illegally marketing unapproved and misbranded botulinum toxin products, [...]
Emerald Heights Social Accountability Committee Donates $305,000 to Support 15 Charities Benefiting Local Communities
05/11/2025
REDMOND, Wash., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Emerald Heights, a leading nonprofit senior living community, proudly announces a donation of $305,000 to 15 local charities through its Social Accountability Committee [...]
Genmab to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference in London
05/11/2025
Media Release COPENHAGEN, Denmark; November 5, 2025 Genmab A/S (Nasdaq: GMAB ) announced today that its Chief Executive Officer Jan Van de Winkel and C hief F inancial O fficer Anthony Pagano will participate in a [...]
UPDATE - MMI Receives IDE Approval from FDA for First Robotic Microsurgical Study in Alzheimer’s Patients
05/11/2025
First-of-its-kind study represents the potential for robotic-enabled microsurgical intervention for neurodegenerative diseases, including Alzheimer’s JACKSONVILLE, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- MMI (Medical [...]
VALNEVA Déclaration d’actions et de droits de vote : 31 octobre 2025
05/11/2025
VALNEVA Déclaration d’actions et de droits de vote 31 octobre 2025 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège social : 6 [...]
VALNEVA Declaration of shares and voting rights: October 31, 2025
05/11/2025
VALNEVA Declaration of shares and voting rights October 31, 2025 __________________________________________________________________________________________ Company name: VALNEVA Registered office: 6 rue Alain Bombard, [...]
beyond|AESTHETICS Celebrates 10 Years of Excellence with Grand Holiday Event
05/11/2025
Camarillo, CA, Nov. 05, 2025 (GLOBE NEWSWIRE) -- beyond|AESTHETICS , a leader in the aesthetics industry, is thrilled to announce its 10 Year Anniversary Holiday Event, a spectacular celebration marking a decade of [...]
Idorsia to present new aprocitentan insights at ASN Kidney Week & AHA Scientific Sessions
05/11/2025
New analysis confirms reductions in blood pressure and albuminuria by aprocitentan in patients with true resistant hypertension and high cardiovascular risk – including chronic kidney disease Allschwil, Switzerland – [...]

Pages